Schizophrenia Research logo Elsevier logo

Publisher: Elsevier

Related content
Volume 46, Number 2, 15 December 2000

< previous issue | all issues | next issue >

Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?
pp. 81-89(9)
Authors: Weiser, M.; Shneider-Beeri, M.; Nakash, N.; Brill, N.; Bawnik, O.; Reiss, S.; Hocherman, S.; Davidson, M.

Comparison of cost, dosage and clinical preference for risperidone and olanzapine
pp. 91-96(6)
Authors: Rabinowitz, J.; Lichtenberg, P.; Kaplan, Z.

Reemergence of tardive dyskinesia after discontinuation of clozapine treatment
pp. 107-109(3)
Authors: Yovtcheva, S.P.; Stanley-Tilt, C.; Moles, J.K.

Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials
pp. 111-118(8)
Authors: Coutinho, E.; Fenton, M.; Adams, C.; Campbell, C.

Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia
pp. 119-127(9)
Authors: Apud, J.A.; Egan, M.F.; Wyatt, R.J.

Practice-related improvement in information processing with novel antipsychotic treatment
pp. 139-148(10)
Authors: Harvey, P.D.; Moriarty, P.J.; Serper, M.R.; Schnur, E.; Lieber, D.

A new look at reaction time in schizophrenia
pp. 149-165(17)
Authors: Gale, H.J.; Holzman, P.S.

Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests
pp. 167-174(8)
Authors: Perry, W.; Light, G.A.; Davis, H.; Braff, D.L.

Event-related potentials in a working-memory task in schizophrenics and controls
pp. 175-186(12)
Authors: Low, A.; Rockstroh, B.; Harsch, S.; Berg, P.; Cohen, R.

Memory for temporal order in patients with schizophrenia
pp. 187-193(7)
Authors: Elvevag, B.; Egan, M.F.; Goldberg, T.E.

Reaction time, symptom profiles and course of illness in schizophrenia
pp. 195-201(7)
Authors: Ngan, E.T.C.; Liddle, P.F.

IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness
pp. 203-207(5)
Authors: Sheitman, B.B.; Murray, M.G.; Snyder, J.A.; Silva, S.; Goldman, R.; Chakos, M.; Volavka, J.; Lieberman, J.A.

Short form of the WAIS-III for use with patients with schizophrenia
pp. 209-215(7)
Authors: Blyler, C.R.; Gold, J.M.; Iannone, V.N.; Buchanan, R.W.

Modification of affect perception deficits in schizophrenia
pp. 217-229(13)
Authors: Penn, D.L.; Combs, D.

Is the attentional dysfunction in schizotypy related to anxiety?
pp. 255-267(13)
Author: Braunstein-Bercovitz, H.

Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives
pp. 269-283(15)
Authors: Laurent, A.; Biloa-Tang, M.; Bougerol, T.; Duly, D.; Anchisi, A.; Bosson, J.; Pellat, J.; d'Amato, T.; Dalery, J.

a-b ridge count and schizophrenia
pp. 285-286(2)
Authors: Rosa, A.; Marcelis, M.; Fananas, L.; van Os, J.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page